Nerinetide

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNerinetide
Drug Alias NameNerinetide - Arbor Vita Corporation/NoNOTatNR2B9cTat NR2B9cTat-NR2B9cNA-1
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDisks large homolog 4 inhibitors
TargetsDisks large homolog 4
Therapy Area/IndicationsStrokeSubarachnoid HemorrhageBrain Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[13
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNono IncArbor Vita Corporation
China Registration ClassN/A

Develop Information

Active CompaniesNono Inc
Inactive CompaniesArbor Vita Corporation
Active IndicationsStrokeBrain Ischemia
Inactive IndicationsSubarachnoid Hemorrhage

Other Information

ATC CodeN/A
Related LinksN/A